Europe — EMA
Niksol (Silodosin)
GNH USA supplies Niksol (Silodosin), a alpha‑1 adrenergic receptor antagonist for benign prostatic hyperplasia. Request a quote for global supply.
Request sourcing
What is Silodosin?
Silodosin, the active ingredient in Niksol, is a alpha-1 adrenergic receptor antagonist presented as a unknown/unknown for oral use. It treats benign prostatic hyperplasia in adult men by relaxing smooth muscle in the prostate and bladder, thereby improving urinary flow. GNH USA supplies Niksol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Silodosin used for?
Silodosin is indicated for conditions related to benign prostatic hyperplasia and its associated urinary symptoms. - Benign prostatic hyperplasia (BPH): reduces urinary obstruction and improves urine flow. - Lower urinary tract symptoms due to BPH: alleviates frequency, urgency and nocturia.
What are the side effects of Silodosin?
Silodosin may cause a range of adverse reactions, most of which are dose‑related and reversible.
Common Side Effects: - Dizziness: sensation of light‑headedness, especially after standing. - Abnormal ejaculation: reduced or absent seminal emission. - Nasal congestion: feeling of a blocked nose. - Diarrhea: loose stools occurring intermittently.
Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Syncope: sudden loss of consciousness. - Priapism: prolonged, painful erection requiring immediate medical attention.
What precautions apply to Silodosin?
Before prescribing Silodosin, clinicians should consider several safety aspects. - Cardiovascular assessment: monitor blood pressure and heart rate, especially in patients with existing hypotension. - Renal function: evaluate kidney status, as impairment may affect drug clearance. - Hepatic function: adjust use in patients with significant liver disease. - Concomitant alpha‑blockers: avoid combined use to reduce risk of additive hypotensive effects. - Storage: Store below 25°C: keep in the original container, protect from moisture and direct sunlight.
What does Silodosin interact with?
Silodosin can interact with other medicines, altering its efficacy or safety profile.
Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole): may increase silodosin plasma levels. - Potent CYP3A4 inducers (e.g., rifampin): may reduce therapeutic effect. - Other alpha‑adrenergic antagonists: additive blood‑pressure lowering.
Moderate Interactions (Monitor Closely):\n- Diuretics: may enhance orthostatic hypotension. - Antihypertensive agents: require blood pressure monitoring.



